It has been suggested that APOE4 Parkinson’s disease carriers present more severe cortical atrophy (Wakabayashi et al., 1998; Li et al., 2004) and more frequent cognitive decline than patients without an APOE4 allele (Irwin et al., 2012). The gene discussed is APOE; the disease is Parkinson disease.